Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
2.250
+0.030 (1.35%)
At close: Apr 2, 2026, 4:00 PM EDT
2.240
-0.010 (-0.44%)
After-hours: Apr 2, 2026, 7:00 PM EDT
Evolent Health Revenue
Revenue (ttm)
$1.41B
Revenue Growth
-44.91%
P/S Ratio
0.13
Revenue / Employee
$446,721
Employees
4,200
Market Cap
251.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 2.55B | 590.85M | 30.09% |
| Dec 31, 2023 | 1.96B | 611.88M | 45.26% |
| Dec 31, 2022 | 1.35B | 444.06M | 48.91% |
| Dec 31, 2021 | 907.96M | -16.68M | -1.80% |
| Dec 31, 2020 | 924.64M | 237.52M | 34.57% |
| Dec 31, 2019 | 687.12M | 60.06M | 9.58% |
| Dec 31, 2018 | 627.06M | 192.11M | 44.17% |
| Dec 31, 2017 | 434.95M | 180.76M | 71.11% |
| Dec 31, 2016 | 254.19M | 157.31M | 162.38% |
| Dec 31, 2015 | 96.88M | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | 25.67M | 17.33M | 207.58% |
| Dec 31, 2012 | 8.35M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Claritev | 965.41M |
| TruBridge | 346.84M |
| Definitive Healthcare | 241.52M |
| Weave Communications | 239.02M |
| So-Young International | 217.80M |
| LifeMD | 194.06M |
| Spok Holdings | 139.71M |
| National Research | 137.39M |
EVH News
- 14 days ago - Evolent announces appointment of Archie Mayani as chief product officer - PRNewsWire
- 5 weeks ago - Evolent to Participate in Upcoming Investor Conferences - PRNewsWire
- 5 weeks ago - Evolent Health: Cheap, Levered, But Ready To Rebound - Seeking Alpha
- 5 weeks ago - Evolent Health, Inc. (EVH) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results - PRNewsWire
- 2 months ago - Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026 - PRNewsWire
- 3 months ago - Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08 - PRNewsWire
- 5 months ago - Evolent Health, Inc. (EVH) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha